Baidu
map

2021年11月17日简报:新冠疫情对心理健康的影响或将持续多年;国内老年人新冠疫苗接种率仍需大幅提高;辉瑞新冠口服药允许95个国家仿制

2021-11-17 MedSci整理 MedSci整理

截至北京时间2021年11月17日7时01分,Worldometers世界实时统计数据显示,全球累计确诊新冠肺炎(COVID-19)病例超过2亿5503万例,新增465,781例,达到255,036,

截至北京时间2021年11月17日7时01分,Worldometers世界实时统计数据显示,全球累计确诊新冠肺炎COVID-19)病例超过2亿5503万例,新增465,781例,达到255,036,589例。累计死亡病例512.8万例,达到5,128,938例。新增死亡为6,825例。康复为230,550,175例,重症和危重症病人达到78,008例;全球新冠确诊病例超过100万例的国家达36个,112个国家病例超10万例。昨日报道:2021年11月16日简报:国内下一步将推出最优加强免疫组合;国内已经有13款新冠疫苗进入了临床三期;新加坡12岁及以上人口新冠疫苗接种率超94%

新冠疫情对心理健康的影响或将持续多年

2020年,因新冠疫情导致全球新增5320万抑郁障碍患者和7620万焦虑障碍患者。而在疫情期间,我国青少年抑郁发生率显著高于疫情前的水平。如何远离恐慌和无措,特别是如何应对因疫情产生的创伤后应激障碍,值得关注。

对于更多没有感染的正常人,在疫情常态化的防控与管理中,大家既要注意防护,警惕可能出现的感染危险,又要正常开展工作和学习。在这一过程中,一些行业受到疫情冲击,有些人面临着降薪、失业,陷入双重压力中。

持续的高压之下,人们很容易出现各种负面情绪。随着焦虑和恐惧的增加,情绪的起伏会影响生活节奏,对未来充满不确定感。

疫情常态化下,更需要心情保持放松的常态化,尽快适应新的生活方式和节奏。结合目前的情况重新调整自己的防护措施、生活和工作计划,和家人朋友多沟通交流缓解内心的焦虑。

过去三周内 美国单日新增新冠病例数增加26.6%

根据美国疾病控制和预防中心当地时间11月15日公布的数据,自10月中旬以来,美国新冠肺炎确诊病例数持续上升。在过去的三周内,每日新增新冠病例数增加了26.6%。美国疾控中心数据显示,截至11月14日,美国过去7日内平均每日新增病例80823例。

对此,美国国家过敏症和传染病研究所所长安东尼·福奇警告称,只要未接种疫苗的美国人达到一定数量,今年年末美国将暴发第五波新冠疫情。

老年人新冠疫苗接种率仍需大幅提高

我国自去年12月份开始接种新冠疫苗,截至15日累计接种新冠疫苗已超过23.96亿剂次。国务院联防联控机制科研攻关组疫苗研发专班工作组组长郑忠伟近日接受央视专访时表示,我国老年人的接种率仍需要大幅提高,真正做到大幅度降低人群的重症率和死亡率。

“目前全球累计因新冠死亡超过500万例,平均年龄在70岁左右。近期一些数据统计显示,65岁以上的老人、75岁以上的老人、85岁以上的老人,相较于年轻人,重症风险分别是5倍、7倍、9倍,死亡风险分别是90倍、220倍、570倍。”郑忠伟介绍,目前国内流行的主要病毒株就是德尔塔株,当前推进新冠疫苗接种的一个关键问题是,要全力推进老年人尤其是高龄老年人新冠疫苗应接尽接。老年人的接种率是相对偏低的,而老人感染新冠的风险是远远高于年轻人的。老年人除了有过敏等情况,或者是属于疾病的急性发作期,其他都是可以接种的。目前我国的新冠病毒疫苗接种率是世界领先的,但老年人的接种率仍需要大幅提高,才能真正做到大幅度降低人群的重症率和死亡率。

“目前全球累计因新冠死亡超过500万例,平均年龄在70岁左右。近期一些数据统计显示,65岁以上的老人、75岁以上的老人、85岁以上的老人,相较于年轻人,重症风险分别是5倍、7倍、9倍,死亡风险分别是90倍、220倍、570倍。”郑忠伟介绍,目前国内流行的主要病毒株就是德尔塔株,当前推进新冠疫苗接种的一个关键问题是,要全力推进老年人尤其是高龄老年人新冠疫苗应接尽接。老年人的接种率是相对偏低的,而老人感染新冠的风险是远远高于年轻人的。老年人除了有过敏等情况,或者是属于疾病的急性发作期,其他都是可以接种的。目前我国的新冠病毒疫苗接种率是世界领先的,但老年人的接种率仍需要大幅提高,才能真正做到大幅度降低人群的重症率和死亡率。

辉瑞授权制造平价抗新冠病毒口服药,允许仿制药生产商为95个中低收入国家生产平价的新冠药物

辉瑞公司达成了一项授权许可协议,允许仿制药生产商为95个中低收入国家生产平价的新冠药物,跟进此前默克公司的类似举措。

辉瑞在周二的一份声明中表示,它已与联合国支持的药品专利联盟(MPP)签署一项协议,一旦获得监管机构的授权,该实验性药物将授权给仿制药生产商生产,可供应给约占全球人口53%的国家及地区。辉瑞和药品专利联盟说,除了低收入和中低收入国家,该协议还包括撒哈拉以南非洲的一些中高收入国家,以及过去五年中从中低收入状态转变为中高收入状态的国家。

全球疫情走势

德国多地收紧防疫措施 未接种疫苗人群社交活动受限

根据德国疾控机构当地时间16日数据,截至16日0时,德国7天内每10万人中的发病率上升至312.4,已连续9日创最高纪录。德国多个联邦州宣布收紧防疫措施。

巴登-符腾堡州州长克莱驰曼宣布,该州将于17日起实行“已接种、已康复”的“2G”防疫原则,这意味着未接种疫苗者基本被排除于公共生活之外。克莱驰曼表示,由于重症监护病床的占用率急剧升高,该州已达到疫情警戒级别。

菲律宾将为医护人员接种新冠疫苗加强针 科兴疫苗被推荐使用

当地时间15日晚,菲律宾卫生部发布声明称,菲律宾计划从17日开始,为完成两剂新冠疫苗接种的医护人员接种加强针。菲律宾卫生部在声明中称,基于菲律宾食品与药物管理局已批准的紧急使用授权,无论此前接种的是何种疫苗,卫生部都推荐使用莫德纳、辉瑞和科兴疫苗作为加强针。如果前两针接种的都是科兴疫苗,则推荐使用科兴疫苗作为加强针。

青海西宁停止寄递国内32个中高风险地区邮快件

近期,青海西宁市邮政管理局督导邮政快递企业对来自国内32个中高风险地区寄往西宁的邮快件以及国际邮快件一律停止寄递,对已经发往西宁的邮快件实施拦截、隔离管控,全面消杀、就地封存,启动后续处理机制,加强对封存邮快件的消杀、核酸检测和处置工作,切实防范疫情通过寄递渠道传播和蔓延。

美国12个州因医护人员疫苗强制令起诉拜登政府

据美国《国会山报》当地时间11月16日报道,美国12个州正在联合对拜登政府授权的、针对医护人员的疫苗强制令进行起诉,称该命令违反多条联邦法律。

该诉讼于当地时间11月15日提起,诉讼书中称,美国医疗保险和医疗补助服务中心颁布的医护人员疫苗强制令,超出了该机构的法定权利,并违反了《社会保障法》对招聘和解雇医护人员的相关规定。诉讼方还指控该授权违反了支出条款、反强占原则、保护各州权利的第十修正案以及其他多条联邦法律。

版权声明:
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料,版权均属于梅斯医学所有。非经授权,任何媒体、网站或个人不得转载,授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章,或“梅斯号”自媒体发布的文章,仅系出于传递更多信息之目的,本站仅负责审核内容合规,其内容不代表本站立场,本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系,我们将立即进行删除处理。
在此留言
评论区 (6)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=2078680, encodeId=7e8920e868030, content=<a href='/topic/show?id=a34956696a7' target=_blank style='color:#2F92EE;'>#接种率#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=84, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=56696, encryptionId=a34956696a7, topicName=接种率)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7a9987, createdName=gous, createdTime=Thu Mar 31 04:43:01 CST 2022, time=2022-03-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2060882, encodeId=f597206088245, content=<a href='/topic/show?id=49f63823396' target=_blank style='color:#2F92EE;'>#口服药#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=71, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=38233, encryptionId=49f63823396, topicName=口服药)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ed25376, createdName=gdsun, createdTime=Thu Apr 14 06:43:01 CST 2022, time=2022-04-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1074976, encodeId=a37d10e497649, content=学习学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=81, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210901/969603a2377544169c0528539edd5ab7/50bbe992202d43569f6cc40d89829e36.jpg, createdBy=b54c5537441, createdName=智慧药, createdTime=Mon Nov 29 09:11:37 CST 2021, time=2021-11-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1072712, encodeId=92f010e2712d0, content=学习学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=86, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210901/969603a2377544169c0528539edd5ab7/50bbe992202d43569f6cc40d89829e36.jpg, createdBy=b54c5537441, createdName=智慧药, createdTime=Mon Nov 22 09:14:13 CST 2021, time=2021-11-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1258118, encodeId=55601258118ad, content=<a href='/topic/show?id=f538e0501e9' target=_blank style='color:#2F92EE;'>#疫苗接种#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=72, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=70501, encryptionId=f538e0501e9, topicName=疫苗接种)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=5c0050, createdName=lishiwen, createdTime=Thu Nov 18 22:43:01 CST 2021, time=2021-11-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1071313, encodeId=c85b10e1313ab, content=学习学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=73, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210901/969603a2377544169c0528539edd5ab7/50bbe992202d43569f6cc40d89829e36.jpg, createdBy=b54c5537441, createdName=智慧药, createdTime=Thu Nov 18 09:27:14 CST 2021, time=2021-11-18, status=1, ipAttribution=)]
    2022-03-31 gous
  2. [GetPortalCommentsPageByObjectIdResponse(id=2078680, encodeId=7e8920e868030, content=<a href='/topic/show?id=a34956696a7' target=_blank style='color:#2F92EE;'>#接种率#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=84, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=56696, encryptionId=a34956696a7, topicName=接种率)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7a9987, createdName=gous, createdTime=Thu Mar 31 04:43:01 CST 2022, time=2022-03-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2060882, encodeId=f597206088245, content=<a href='/topic/show?id=49f63823396' target=_blank style='color:#2F92EE;'>#口服药#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=71, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=38233, encryptionId=49f63823396, topicName=口服药)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ed25376, createdName=gdsun, createdTime=Thu Apr 14 06:43:01 CST 2022, time=2022-04-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1074976, encodeId=a37d10e497649, content=学习学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=81, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210901/969603a2377544169c0528539edd5ab7/50bbe992202d43569f6cc40d89829e36.jpg, createdBy=b54c5537441, createdName=智慧药, createdTime=Mon Nov 29 09:11:37 CST 2021, time=2021-11-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1072712, encodeId=92f010e2712d0, content=学习学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=86, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210901/969603a2377544169c0528539edd5ab7/50bbe992202d43569f6cc40d89829e36.jpg, createdBy=b54c5537441, createdName=智慧药, createdTime=Mon Nov 22 09:14:13 CST 2021, time=2021-11-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1258118, encodeId=55601258118ad, content=<a href='/topic/show?id=f538e0501e9' target=_blank style='color:#2F92EE;'>#疫苗接种#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=72, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=70501, encryptionId=f538e0501e9, topicName=疫苗接种)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=5c0050, createdName=lishiwen, createdTime=Thu Nov 18 22:43:01 CST 2021, time=2021-11-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1071313, encodeId=c85b10e1313ab, content=学习学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=73, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210901/969603a2377544169c0528539edd5ab7/50bbe992202d43569f6cc40d89829e36.jpg, createdBy=b54c5537441, createdName=智慧药, createdTime=Thu Nov 18 09:27:14 CST 2021, time=2021-11-18, status=1, ipAttribution=)]
    2022-04-14 gdsun
  3. [GetPortalCommentsPageByObjectIdResponse(id=2078680, encodeId=7e8920e868030, content=<a href='/topic/show?id=a34956696a7' target=_blank style='color:#2F92EE;'>#接种率#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=84, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=56696, encryptionId=a34956696a7, topicName=接种率)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7a9987, createdName=gous, createdTime=Thu Mar 31 04:43:01 CST 2022, time=2022-03-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2060882, encodeId=f597206088245, content=<a href='/topic/show?id=49f63823396' target=_blank style='color:#2F92EE;'>#口服药#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=71, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=38233, encryptionId=49f63823396, topicName=口服药)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ed25376, createdName=gdsun, createdTime=Thu Apr 14 06:43:01 CST 2022, time=2022-04-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1074976, encodeId=a37d10e497649, content=学习学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=81, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210901/969603a2377544169c0528539edd5ab7/50bbe992202d43569f6cc40d89829e36.jpg, createdBy=b54c5537441, createdName=智慧药, createdTime=Mon Nov 29 09:11:37 CST 2021, time=2021-11-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1072712, encodeId=92f010e2712d0, content=学习学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=86, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210901/969603a2377544169c0528539edd5ab7/50bbe992202d43569f6cc40d89829e36.jpg, createdBy=b54c5537441, createdName=智慧药, createdTime=Mon Nov 22 09:14:13 CST 2021, time=2021-11-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1258118, encodeId=55601258118ad, content=<a href='/topic/show?id=f538e0501e9' target=_blank style='color:#2F92EE;'>#疫苗接种#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=72, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=70501, encryptionId=f538e0501e9, topicName=疫苗接种)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=5c0050, createdName=lishiwen, createdTime=Thu Nov 18 22:43:01 CST 2021, time=2021-11-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1071313, encodeId=c85b10e1313ab, content=学习学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=73, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210901/969603a2377544169c0528539edd5ab7/50bbe992202d43569f6cc40d89829e36.jpg, createdBy=b54c5537441, createdName=智慧药, createdTime=Thu Nov 18 09:27:14 CST 2021, time=2021-11-18, status=1, ipAttribution=)]
    2021-11-29 智慧药

    学习学习

    0

  4. [GetPortalCommentsPageByObjectIdResponse(id=2078680, encodeId=7e8920e868030, content=<a href='/topic/show?id=a34956696a7' target=_blank style='color:#2F92EE;'>#接种率#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=84, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=56696, encryptionId=a34956696a7, topicName=接种率)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7a9987, createdName=gous, createdTime=Thu Mar 31 04:43:01 CST 2022, time=2022-03-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2060882, encodeId=f597206088245, content=<a href='/topic/show?id=49f63823396' target=_blank style='color:#2F92EE;'>#口服药#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=71, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=38233, encryptionId=49f63823396, topicName=口服药)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ed25376, createdName=gdsun, createdTime=Thu Apr 14 06:43:01 CST 2022, time=2022-04-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1074976, encodeId=a37d10e497649, content=学习学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=81, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210901/969603a2377544169c0528539edd5ab7/50bbe992202d43569f6cc40d89829e36.jpg, createdBy=b54c5537441, createdName=智慧药, createdTime=Mon Nov 29 09:11:37 CST 2021, time=2021-11-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1072712, encodeId=92f010e2712d0, content=学习学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=86, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210901/969603a2377544169c0528539edd5ab7/50bbe992202d43569f6cc40d89829e36.jpg, createdBy=b54c5537441, createdName=智慧药, createdTime=Mon Nov 22 09:14:13 CST 2021, time=2021-11-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1258118, encodeId=55601258118ad, content=<a href='/topic/show?id=f538e0501e9' target=_blank style='color:#2F92EE;'>#疫苗接种#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=72, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=70501, encryptionId=f538e0501e9, topicName=疫苗接种)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=5c0050, createdName=lishiwen, createdTime=Thu Nov 18 22:43:01 CST 2021, time=2021-11-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1071313, encodeId=c85b10e1313ab, content=学习学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=73, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210901/969603a2377544169c0528539edd5ab7/50bbe992202d43569f6cc40d89829e36.jpg, createdBy=b54c5537441, createdName=智慧药, createdTime=Thu Nov 18 09:27:14 CST 2021, time=2021-11-18, status=1, ipAttribution=)]
    2021-11-22 智慧药

    学习学习

    0

  5. [GetPortalCommentsPageByObjectIdResponse(id=2078680, encodeId=7e8920e868030, content=<a href='/topic/show?id=a34956696a7' target=_blank style='color:#2F92EE;'>#接种率#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=84, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=56696, encryptionId=a34956696a7, topicName=接种率)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7a9987, createdName=gous, createdTime=Thu Mar 31 04:43:01 CST 2022, time=2022-03-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2060882, encodeId=f597206088245, content=<a href='/topic/show?id=49f63823396' target=_blank style='color:#2F92EE;'>#口服药#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=71, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=38233, encryptionId=49f63823396, topicName=口服药)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ed25376, createdName=gdsun, createdTime=Thu Apr 14 06:43:01 CST 2022, time=2022-04-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1074976, encodeId=a37d10e497649, content=学习学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=81, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210901/969603a2377544169c0528539edd5ab7/50bbe992202d43569f6cc40d89829e36.jpg, createdBy=b54c5537441, createdName=智慧药, createdTime=Mon Nov 29 09:11:37 CST 2021, time=2021-11-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1072712, encodeId=92f010e2712d0, content=学习学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=86, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210901/969603a2377544169c0528539edd5ab7/50bbe992202d43569f6cc40d89829e36.jpg, createdBy=b54c5537441, createdName=智慧药, createdTime=Mon Nov 22 09:14:13 CST 2021, time=2021-11-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1258118, encodeId=55601258118ad, content=<a href='/topic/show?id=f538e0501e9' target=_blank style='color:#2F92EE;'>#疫苗接种#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=72, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=70501, encryptionId=f538e0501e9, topicName=疫苗接种)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=5c0050, createdName=lishiwen, createdTime=Thu Nov 18 22:43:01 CST 2021, time=2021-11-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1071313, encodeId=c85b10e1313ab, content=学习学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=73, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210901/969603a2377544169c0528539edd5ab7/50bbe992202d43569f6cc40d89829e36.jpg, createdBy=b54c5537441, createdName=智慧药, createdTime=Thu Nov 18 09:27:14 CST 2021, time=2021-11-18, status=1, ipAttribution=)]
  6. [GetPortalCommentsPageByObjectIdResponse(id=2078680, encodeId=7e8920e868030, content=<a href='/topic/show?id=a34956696a7' target=_blank style='color:#2F92EE;'>#接种率#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=84, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=56696, encryptionId=a34956696a7, topicName=接种率)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7a9987, createdName=gous, createdTime=Thu Mar 31 04:43:01 CST 2022, time=2022-03-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2060882, encodeId=f597206088245, content=<a href='/topic/show?id=49f63823396' target=_blank style='color:#2F92EE;'>#口服药#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=71, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=38233, encryptionId=49f63823396, topicName=口服药)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ed25376, createdName=gdsun, createdTime=Thu Apr 14 06:43:01 CST 2022, time=2022-04-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1074976, encodeId=a37d10e497649, content=学习学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=81, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210901/969603a2377544169c0528539edd5ab7/50bbe992202d43569f6cc40d89829e36.jpg, createdBy=b54c5537441, createdName=智慧药, createdTime=Mon Nov 29 09:11:37 CST 2021, time=2021-11-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1072712, encodeId=92f010e2712d0, content=学习学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=86, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210901/969603a2377544169c0528539edd5ab7/50bbe992202d43569f6cc40d89829e36.jpg, createdBy=b54c5537441, createdName=智慧药, createdTime=Mon Nov 22 09:14:13 CST 2021, time=2021-11-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1258118, encodeId=55601258118ad, content=<a href='/topic/show?id=f538e0501e9' target=_blank style='color:#2F92EE;'>#疫苗接种#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=72, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=70501, encryptionId=f538e0501e9, topicName=疫苗接种)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=5c0050, createdName=lishiwen, createdTime=Thu Nov 18 22:43:01 CST 2021, time=2021-11-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1071313, encodeId=c85b10e1313ab, content=学习学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=73, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210901/969603a2377544169c0528539edd5ab7/50bbe992202d43569f6cc40d89829e36.jpg, createdBy=b54c5537441, createdName=智慧药, createdTime=Thu Nov 18 09:27:14 CST 2021, time=2021-11-18, status=1, ipAttribution=)]
    2021-11-18 智慧药

    学习学习

    0

相关资讯

2021年10月20日简报:本土多省份出现少量病例感染,多省严格管控;FDA将允许民众混打不同品牌新冠疫苗加强针;英国疫情反弹,但是死亡维持在低水平

截至北京时间2021年10月20日7时01分,Worldometers世界实时统计数据显示,全球累计确诊新冠肺炎(COVID-19)病例超过2亿4228万例,新增397,761例,达到242,286,

2021年11月10日简报:英美全面开放国际旅行,中国疫苗被认可;法国要求65岁以上老人接种第三剂新冠疫苗;以色列打加强针后,疫情再度得到控制

截至北京时间2021年11月10日8时01分,Worldometers世界实时统计数据显示,全球累计确诊新冠肺炎(COVID-19)病例超过2亿5149万例,新增420,552例,达到251,494,

医学英语:WHO警告新冠疫情可能会持续至2022年末

世界卫生组织表示,由于贫穷国家无法获得所需疫苗,新冠疫情很可能将持续到2022年末。目前非洲的疫苗接种率仅为5%,而其他大陆的疫苗接种率基本都达到了40%。

北京本轮疫情已波及三区,严格出京审批!什么方法可以遏制新冠的传播吗?

秋冬季节的到来可能使得新冠病毒在环境中存活的时间变长,加大了传染风险。仅仅7天,本轮疫情已波及陕西、宁夏、内蒙古、北京等11省区市,而北京本轮疫情已波及昌平区、丰台区、海淀区三区。

2021年10月24日简报:新一波全球疫情开始抬头,第三新冠的冬天可能并不平坦;新的变异病毒品种为“AY.4.2”,可能会引发广泛流行

截至北京时间2021年10月24日7时01分,Worldometers世界实时统计数据显示,全球累计确诊新冠肺炎(COVID-19)病例超过2亿4408万例,新增371,400例,达到244,085,

Baidu
map
Baidu
map
Baidu
map